GSK3B and colorectal carcinoma: Decreased GSK3β protein levels increased the expression of WNT/β-catenin/Cyclin D1 pathway-related proteins, leading to cell-cycle progression from G0 to G1 and ultimately promoting the proliferation of CRC cells.